We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current GMED market cap is 11.45B. The company's latest EPS is USD 0.9024 and P/E is 92.22.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 383.64M | 616.53M | 606.7M | 629.69M | 625.71M |
| Operating Income | 3.14M | 10.12M | 8M | 49.65M | 48.1M |
| Net Income | 998k | 15.03M | -7.12M | 31.76M | 51.84M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 785.37M | 789.04M | 958.1M | 1.02B | 1.57B |
| Operating Income | 171.99M | 111.43M | 177.87M | 230.29M | 133.14M |
| Net Income | 155.21M | 102.29M | 149.19M | 190.17M | 122.87M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 5.36B | 5.09B | 4.94B | 4.99B | 5.09B |
| Total Liabilities | 1.17B | 1.09B | 1.02B | 1.02B | 1.02B |
| Total Equity | 4.19B | 4B | 3.92B | 3.98B | 4.07B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.53B | 1.68B | 1.96B | 2.08B | 5.09B |
| Total Liabilities | 129.63M | 173.19M | 215.88M | 229.75M | 1.09B |
| Total Equity | 1.4B | 1.51B | 1.74B | 1.85B | 4B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 138.83M | 243.5M | 52.39M | 106.65M | 330.27M |
| Investing | -17.65M | 302.97M | -46.58M | -56.96M | -71.93M |
| Financing | 5.45M | -231.82M | -115.72M | -107.01M | -87.43M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 171.98M | 198.79M | 276.27M | 178.47M | 243.5M |
| Investing | -140.28M | -117.32M | -375.94M | -110.36M | 302.97M |
| Financing | 24.44M | -38.66M | 54.15M | -109.96M | -231.82M |
| Market Cap | 11.45B |
| Price to Earnings Ratio | 92.22 |
| Price to Sales Ratio | 7.22 |
| Price to Cash Ratio | 24.25 |
| Price to Book Ratio | 2.83 |
| Dividend Yield | - |
| Shares Outstanding | 136.17M |
| Average Volume (1 week) | 618.85k |
| Average Volume (1 Month) | 846.47k |
| 52 Week Change | 58.24% |
| 52 Week High | 87.22 |
| 52 Week Low | 49.33 |
| Spread (Intraday) | 0.13 (0.15%) |
| Company Name | Globus Medical Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.globusmedical.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
